Differential pathophysiological mechanisms between CHS and EHS While CHS and EHS share core pathogenic pathways (e.g., hyperthermia, inflammation, cell death), their mechanistic features differ significantly due to distinct patient demographics and triggers: Inflammatory kinetics EHS (predominant in young, active individuals) is characterized by rapid, exertion-amplified inflammatory responses
After TBI, oxidative stress in cells can cause damage to certain lysosomes
GHK-Cu is a peptide the skin makes naturally that is involved in tissue repair and regeneration 3 Levels naturally decline with age, impacting skin repair, firmness, and collagen production 1 2 Replenishing GHK-Cu levels may help improve the appearance of fine lines, texture, and overall tone 1 4 May help protect from environmental exposures that drive skin aging and wrinkles 5 Supports the skins natural repair processes without irritation, redness, or peeling 1 Compounded by US-licensed pharmacies GHK-CU BENEFITS Regenerative Skin Support Supports local renewal and regeneration within the epidermis and dermis 1 Supports collagen production, hydration, regeneration, anti-inflammatory, and antioxidant effects 1 3 4 May help reinforce skin barrier integrity and improve resilience over time 6 A gentler alternative to retinoids and resurfacing treatments Apply topically 5x weekly for a simple, consistent routine that takes under a minute GHK-Cu has not been approved by the FDA for these uses
Overall survival and independent review of response in CheckMate 214 with 42-month follow-up: First-line nivolumab + ipilimumab (N+I) versus sunitinib (S) in patients (pts) with advanced renal cell carcinoma (aRCC)
Most users notice subtle improvements in skin hydration and texture within 2-4 weeks
